| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10019798 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS10006499 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS10059337 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS10060312 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS10060313 | HBV | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
| TVIS44014764 | HTLV-1 | ENSG00000198650.11 | protein_coding | TAT | No | No | 6898 | P17735 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TAT |
|---|---|
| DrugBank ID | DB00142 |
| Drug Name | Glutamic acid |
| Target ID | BE0000692 |
| UniProt ID | P17735 |
| Regulation Type | |
| PubMed IDs | 16840830 |
| Citations | Ozturk M, Chiu CY, Akdeniz N, Jenq SF, Chang SC, Hsa CY, Jap TS: Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1. J Endocrinol Invest. 2006 Jun;29(6):523-7. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Glutamic acid and derivatives |
| SMILES | N[C@@H](CCC(O)=O)C(O)=O |
| Pathways | Histidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Purine Nucleoside Phosphorylase Deficiency; Tyrosine Metabolism; Ketoprofen Action Pathway; Glutamate Metabolism; Argininosuccinic Aciduria; Salla Disease/Infantile Sialic Acid Storage Disease; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Celecoxib Action Pathway; Glycine and Serine Metabolism; Suprofen Action Pathway; Indomethacin Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Sialuria or French Type Sialuria; Ibuprofen Action Pathway; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Arginine and Proline Metabolism; Purine Metabolism; Diflunisal Action Pathway; Etodolac Action Pathway; Ammonia Recycling |
| PharmGKB | PA449776 |
| ChEMBL | CHEMBL575060 |
